News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zafgen (ZFGN) Announces Closing Of Initial Public Offering And Full Exercise Of Over-Allotment Option


6/25/2014 8:42:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass., June 24, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the closing of its initial public offering of 6,900,000 shares of its common stock at a price to the public of $16.00 per share, before underwriting discounts, which includes the exercise in full by the underwriters of their option to purchase up to 900,000 additional shares of common stock. All of the common stock was offered by Zafgen. The company's common stock is listed on The NASDAQ Global Market under the symbol "ZFGN."

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Zafgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES